Association of Common Variants in <i>OLA1</i> Gene with Preclinical Atherosclerosis

Association of Common Variants in <i>OLA1</i> Gene with Preclinical Atherosclerosis

Reactive oxygen species impair the blood vessels, leading to the initiation of atherosclerosis, and migration and proliferation of vascular smooth muscle cells and neovascularization by endothelial cells of vasa vasorum are essential for atherosclerosis development. Obg-like ATPase 1 (OLA1), a negat...

Full description

Bibliographic Details
Main Authors:	Ting-Fong Lin, Chao-Liang Chou, Chu-Jui Hsieh, Yih-Jer Wu, Yi-Cheng Chen, Tzu-Wei Wu, Shu-Xin Lu, Yue-Li Juang, Li-Yu Wang
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	International Journal of Molecular Sciences
Subjects:	atherosclerosis carotid intima–media thickness single nucleotide polymorphism <i>BRCA1</i> <i>OLA1</i> genetic association study
Online Access:	https://www.mdpi.com/1422-0067/23/19/11511

Similar Items

<i>BRCA1</i> and <i>BRCA2</i> Gene Mutations and Lung Cancer Sisk: A Meta-Analysis
by: Yen-Chien Lee, et al.
Published: (2020-04-01)

Predominance of <i>BRCA2</i> Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with <i>BRCA1</i> or <i>BRCA2</i> Mutation
by: Pascal Pujol, et al.
Published: (2022-07-01)

Double Heterozygosity for Rare Deleterious Variants in the <i>BRCA1</i> and <i>BRCA2</i> Genes in a Hungarian Patient with Breast Cancer
by: László Madar, et al.
Published: (2023-10-01)

Fanconi Anaemia, Childhood Cancer and the <i>BRCA</i> Genes
by: Emma R. Woodward, et al.
Published: (2021-09-01)

<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories
by: Ettore Capoluongo, et al.
Published: (2019-10-01)

Real-World Concordance between Germline and Tumour <i>BRCA1/2</i> Status in Epithelial Ovarian Cancer
by: Robert D. Morgan, et al.
Published: (2023-12-01)

Tumour Versus Germline <i>BRCA</i> Testing in Ovarian Cancer: A Single-Site Institution Experience in the United Kingdom
by: Iolia Akaev, et al.
Published: (2021-03-01)

Disequilibrium between <i>BRCA1</i> and <i>BRCA2</i> Circular and Messenger RNAs Plays a Role in Breast Cancer
by: Corentin Levacher, et al.
Published: (2023-04-01)

<i>BRCA1</i> and Metastasis: Outcome of Defective DNA Repair
by: Rehna Krishnan, et al.
Published: (2021-12-01)

The Importance of Extended Analysis Using Current Molecular Genetic Methods Based on the Example of a Cohort of 228 Patients with Hereditary Breast and Ovarian Cancer Syndrome
by: Luise D. Resch, et al.
Published: (2021-09-01)

Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a <i>BRCA1/2</i> Mutation
by: Shuoying Qu, et al.
Published: (2023-12-01)

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in <i>BRCA1</i> or <i>BRCA2</i> Mutation Families
by: Marion Imbert-Bouteille, et al.
Published: (2021-07-01)

Pathogenic <i>BRCA</i> Variants as Biomarkers for Risk in Prostate Cancer
by: Ciara S. McNevin, et al.
Published: (2021-11-01)

Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
by: Robert D. Morgan, et al.
Published: (2023-01-01)

<i>BRCA1/2</i> Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome
by: Trong-Nhan N. Le, et al.
Published: (2022-01-01)

Characterization of BRCA Deficiency in Ovarian Cancer
by: Giovanna Barbero, et al.
Published: (2023-02-01)

<em>BRCA</em> Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies
by: Yen-Chien Lee, et al.
Published: (2021-08-01)

Mutations of <i>BRCA1</i>, <i>BRCA2</i>, and <i>PALB2</i> Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis
by: Matvey M. Tsyganov, et al.
Published: (2023-07-01)

Multitumor Case Series of Germline <i>BRCA1</i>, <i>BRCA2</i> and <i>CHEK2</i>-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors
by: Lisa Kinget, et al.
Published: (2021-08-01)

BRACNAC: A <i>BRCA1</i> and <i>BRCA2</i> Copy Number Alteration Caller from Next-Generation Sequencing Data
by: Andrey Kechin, et al.
Published: (2023-11-01)

Assessing Psychological Morbidity in Cancer-Unaffected <i>BRCA1/2</i> Pathogenic Variant Carriers: A Systematic Review
by: Anna Isselhard, et al.
Published: (2023-03-01)

Recurrent Mutations in <i>BRCA1</i>, <i>BRCA2</i>, <i>RAD51C</i>, <i>PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian Cancer
by: Alicja Łukomska, et al.
Published: (2021-02-01)

Analysis of Italian <i>BRCA1/2</i> Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy
by: Gisella Figlioli, et al.
Published: (2021-01-01)

OLA1 is responsible for normal spindle assembly and SAC activation in mouse oocytes
by: Di Xie, et al.
Published: (2020-01-01)

PLANO DE LAS OLAS DEL GOLFO DE PANAMÁ
by: Manuel A. Grimaldo O.
Published: (2014-09-01)

La irrupción de una nueva ola feminista: ¿La cuarta ola?
by: Doris Lamus Canavate
Published: (2021-02-01)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior <i>BRCA1/2</i> Probability
by: D. Gareth Evans, et al.
Published: (2021-08-01)

Frequency of Germline and Somatic <i>BRCA1</i> and <i>BRCA2</i> Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis
by: Anna Amela Valsecchi, et al.
Published: (2023-04-01)

How Does Dietary Intake Relate to Dispositional Optimism and Health-Related Quality of Life in Germline <i>BRCA1/2</i> Mutation Carriers?
by: Anne Esser, et al.
Published: (2023-03-01)

Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes <i>BReast CAncer 1</i> and <i>BReast CAncer 2</i>
by: Tara Zuhair Kassem, et al.
Published: (2023-08-01)

Comparing Prognosis for <i>BRCA1</i>, <i>BRCA2</i>, and Non-BRCA Breast Cancer
by: Pedro Antunes Meireles, et al.
Published: (2023-12-01)

Transcriptome Patterns of <i>BRCA1</i>- and <i>BRCA2</i>- Mutated Breast and Ovarian Cancers
by: Arsen Arakelyan, et al.
Published: (2021-01-01)

Satisfaction and Quality of Life of Healthy and Unilateral Diseased <i>BRCA1/2</i> Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire
by: Natalie Herold, et al.
Published: (2022-07-01)

<i>BRCA</i> Variations Risk Assessment in Breast Cancers Using Different Artificial Intelligence Models
by: Niyazi Senturk, et al.
Published: (2021-11-01)

Differential Sensitivity of Germline and Somatic <i>BRCA</i> Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer
by: Julie A. Vendrell, et al.
Published: (2023-09-01)

Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond <i>BRCA1/2</i>
by: Daniele Fanale, et al.
Published: (2020-08-01)

A Recurrent <i>BRCA2</i> Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico
by: Hector J. Diaz-Zabala, et al.
Published: (2018-11-01)

The Diagnostic Yield and Implications of Targeted Founder Pathogenic Variant Testing in an Israeli Cohort
by: Aasem Abu Shtaya, et al.
Published: (2023-12-01)

A Population-Based Analysis of <i>BRCA1</i>/<i>2</i> Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study
by: Kyung-Sun Park, et al.
Published: (2021-05-01)

Breast Cancer Mortality among Women with a <i>BRCA1</i> or <i>BRCA2</i> Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program
by: Ellen Warner, et al.
Published: (2020-11-01)